Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

India's Sun Pharma says U.S. FDA to lift ban on Mohali plant exports
India's Sun Pharma says U.S. FDA to lift ban on Mohali plant exports
India's largest drugmaker Sun Pharmaceutical Industries said U.
ADA recommends metformin as the preferred drug treatment for type 2 diabetes
ADA recommends metformin as the preferred drug treatment for type 2 diabetes
The American Diabetes Association (ADA) recommends metformin as the first-line treatment for type 2 diabetes.
Pfizer runs away with pharma brand ad-spending crown, Nielsen data shows
Pfizer runs away with pharma brand ad-spending crown, Nielsen data shows
Pharma companies’ ad spending jumped again last year to $5.
Cancer clinic turns to crowdfunding to boost therapy access
Cancer clinic turns to crowdfunding to boost therapy access
A cancer clinic based in London has taken the unprecedented step of launching a crowdfunding appeal striving to raise £350,000 in order to give more patients access to innovative cost effective treat...
Trump chooses Gottlieb to run FDA; Pharma breathes sigh of relief
Trump chooses Gottlieb to run FDA; Pharma breathes sigh of relief
U.
BI drug gets orphan status for MDS
BI drug gets orphan status for MDS
Boehringer Ingelheim has bagged US orphan drug designation for its anti-CD33 monoclonal antibody BI 836858 for the treatment of myelodysplastic syndromes (MDS).
Glenmark Pharmaceuticals Receives FDA Clearance of IND for GSP 304
Glenmark Pharmaceuticals Receives FDA Clearance of IND for GSP 304
MAHWAH, NJ, USA I March 7, 2017 I Glenmark Pharmaceuticals, a global pharmaceutical company, today announced that the U.
Sanofi and Regeneron Announce Presentation of Positive Data from Long-Term Pivotal Phase 3 CHRONOS Study of Dupixent® (dupilumab) in Moderate-to-Severe Atopic Dermatitis
Sanofi and Regeneron Announce Presentation of Positive Data from Long-Term Pivotal Phase 3 CHRONOS Study of Dupixent® (dupilumab) in Moderate-to-Severe Atopic Dermatitis
TARRYTOWN, NY, USA and PARIS, France -  March 7, 2017 - Regeneron Pharmaceuticals, Inc.
Sanofi gears up for European generic drugs unit sale - sources
Sanofi gears up for European generic drugs unit sale - sources
LONDON/FRANKFURT, March 8 (Reuters) - French drug maker Sanofi is looking to hire advisers for the sale of its European generic drug business by the end of March, sources told Reuters, ahead o...
As biosimilars hit, EU pharma warns against blanket prescribing
As biosimilars hit, EU pharma warns against blanket prescribing
European drugmakers, faced with increasing competition from cut-price copies of complex biotech drugs, cautioned doctors on Thursday to take care when switching patients from an established product to...
French pharmaceutical market to stagnate as government embraces generics to cut healthcare expenditure
French pharmaceutical market to stagnate as government embraces generics to cut healthcare expenditure
The pharmaceuticals market in France is set to decline from $35.
Lupin launches Temovate generic
Lupin launches Temovate generic
BALTIMORE — Lupin has launched its Clobetasol Propionate Topical Solution USP, 0.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand